Emory University Winship Cancer Institute: Ovarian AMH Blood Marker May Help Refine Chemotherapy for Premenopausal Patients With Breast Cancer
August 13, 2026
August 13, 2026
ATLANTA, Georgia, Aug. 13 (TNSjou) -- Emory University Winship Cancer Institute issued the following news release:
* * *
Ovarian AMH blood marker may help refine chemotherapy for premenopausal patients with breast cancer
A blood marker commonly used to measure ovarian reserve may help identify which premenopausal patients with the most common form of breast cancer are most likely to benefit from chemotherapy, according to new research led by Winship Cancer . . .
* * *
Ovarian AMH blood marker may help refine chemotherapy for premenopausal patients with breast cancer
A blood marker commonly used to measure ovarian reserve may help identify which premenopausal patients with the most common form of breast cancer are most likely to benefit from chemotherapy, according to new research led by Winship Cancer . . .